Probiotic supplement as an adjunctive therapy with Ritalin for treatment of attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled randomized clinical trial

被引:14
|
作者
Ghanaatgar, Milad [1 ]
Taherzadeh, Sina [2 ]
Ariyanfar, Shadi [3 ]
Razeghi, Jahromi Soodeh [1 ]
Martami, Fahime [4 ]
Mahmoudi, Gharaei Javad [5 ]
Teimourpour, Amir [6 ]
Shahrivar, Zahra [1 ,5 ]
机构
[1] Shahid Beheshti Univ Med Sci, Dept Clin Nutr & Dietet, Fac Nutr & Food Technol, Natl Nutr & Food Technol Res Inst, Tehran, Iran
[2] Univ Tehran Med Sci, Roozbeh Psychiat Hosp, Tehran, Iran
[3] Washington State Univ, Elson S Floyd Coll Med, Dept Nutr & Exercise Physiol, Vancouver, WA USA
[4] Univ Tehran Med Sci, Sch Nutrit Sci & Dietet, Tehran, Iran
[5] Univ Tehran Med Sci, Roozbeh Hosp, Tehran, Iran
[6] Blood Transfus Res Ctr, High Inst Res & Educ Transfus Med, Tehran, Iran
关键词
Attention-deficit hyperactivity disorder; ADHD; Probiotics; Children; INTESTINAL PERMEABILITY; STIMULANT MEDICATIONS; GENDER-DIFFERENCES; ALLERGIC DISEASES; ADHD; GUT; INFLAMMATION; ASSOCIATION; MICROBIOTA; SCALE;
D O I
10.1108/NFS-12-2021-0388
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Purpose Accumulating evidence highlights the importance of microbiota-directed intervention in neuropsychiatric disorders. This study aims to investigate the effects of probiotic supplements as an adjunct therapy in combination with Ritalin in children with attention-deficit hyperactivity disorder (ADHD). Design/methodology/approach Children with ADHD, aged 6-12 years, who had an intelligent quotient of >= 70 were enrolled in the study. Participants were randomly assigned to either the group that received probiotics or the group that received the placebo in addition to the weight-adjusted dose of Ritalin. Parents were asked to complete the revised Conners Parent Rating Scale-short version (CPRS-RS), and the psychiatrist completed the seven-point Clinical Global Impression-Severity (CGI-S) scale. Two study groups were compared in three time points, including T1 (before intervention), T2 (at the end of fourth week) and T3 (at the end of the eighth week). Findings A total of 38 participants completed the study. After eight weeks of intervention, the probiotic group had a significant improvement regarding CPRS-RS scores in T2 (9.4 unit, p = 0.014) and T3 (18.6 unit, p < 0.001), compared to placebo. In addition, children in the probiotic group had 0.7 unit lower CGI in T3 (p = 0.018) than the placebo group. A significant reduction of CGI scores was observed in each interval (T2 vs T1, T3 vs T2 and T3 vs T1; p < 0.05). This significant change in CGI score between intervals was also detected in the placebo group in T2 vs T1 (p = 0.002) and T3 vs T1 (p < 0.001). Mean CPRS scores of the groups were different in T2 and T3 (p = 0.011 and p < 0.001, respectively) and mean CGI scores of the two study groups were different in T3 (p = 0.018). Originality/value Eight weeks of supplementation with probiotics had a favorable effect on symptoms and severity of ADHD. Therefore, probiotics as an adjuvant treatment might have a promising efficacy regarding the management of ADHD.
引用
收藏
页码:19 / 34
页数:16
相关论文
共 50 条
  • [41] A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Huang, Yu-Shu
    Yeh, Chin-Bin
    Chen, Chin-Hung
    Shang, Chi-Yung
    Gau, Susan Shur-Fen
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2021, 31 (03) : 164 - 178
  • [42] A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder
    Greenhill, LL
    Biederman, J
    Boellner, SW
    Rugino, TA
    Sangal, RB
    Earl, CQ
    Jiang, JG
    Swanson, JM
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (05) : 503 - 511
  • [43] Once-Daily Treatment With Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial
    Young, Joel L.
    Sarkis, Elias
    Qiao, Meihua
    Wietecha, Linda
    CLINICAL NEUROPHARMACOLOGY, 2011, 34 (02) : 51 - 60
  • [44] Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial
    Maryam Rafeiy-Torghabeh
    Amir Ashraf-Ganjouei
    Kamyar Moradi
    Sayna Bagheri
    Mohammad-Reza Mohammadi
    Shahin Akhondzadeh
    European Child & Adolescent Psychiatry, 2021, 30 : 799 - 807
  • [45] Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial
    Rafeiy-Torghabeh, Maryam
    Ashraf-Ganjouei, Amir
    Moradi, Kamyar
    Bagheri, Sayna
    Mohammadi, Mohammad-Reza
    Akhondzadeh, Shahin
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2021, 30 (05) : 799 - 807
  • [46] Ginkgo biloba in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. A randomized, placebo-controlled, trial
    Shakibaei, Fereshteh
    Radmanesh, Mehrsa
    Salari, Elham
    Mahaki, Behzad
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2015, 21 (02) : 61 - 67
  • [47] Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Asadabadi, Mahtab
    Mohammadi, Mohammad-Reza
    Ghanizadeh, Ahmad
    Modabbernia, Amirhossein
    Ashrafi, Mandana
    Hassanzadeh, Elmira
    Forghani, Saeedeh
    Akhondzadeh, Shahin
    PSYCHOPHARMACOLOGY, 2013, 225 (01) : 51 - 59
  • [48] Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Mahtab Asadabadi
    Mohammad-Reza Mohammadi
    Ahmad Ghanizadeh
    Amirhossein Modabbernia
    Mandana Ashrafi
    Elmira Hassanzadeh
    Saeedeh Forghani
    Shahin Akhondzadeh
    Psychopharmacology, 2013, 225 : 51 - 59
  • [49] A Double-Blind, Randomized, Placebo/Active Controlled Crossover Evaluation of the Efficacy and Safety of Ritalin® LA in Children with Attention-Deficit/Hyperactivity Disorder in a Laboratory Classroom Setting
    Schulz, Eberhard
    Fleischhaker, Christian
    Hennighausen, Klaus
    Heiser, Philip
    Oehler, Klaus-Uwe
    Linder, Martin
    Haessler, Frank
    Huss, Michael
    Warnke, Andreas
    Schmidt, Martin
    Schulte-Markworth, Michael
    Sieder, Christian
    Klatt, Jan
    Tracik, Ferenc
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (05) : 377 - 385
  • [50] Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder
    Bilici, M
    Yildirim, F
    Kandil, S
    Bekaroglu, M
    Yildirmis, S
    Deger, O
    Ülgen, M
    Yildiran, A
    Aksu, H
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (01) : 181 - 190